Researcher.Life Logo

Current Drug Therapy : Impact Factor & More

eISSN: 2212-3903pISSN: 1574-8855

Key Metrics

CiteScore
0.9
SNIP
0.32
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Current Drug Therapy

Current Drug Therapy Journal Specifications

Overview
Publisher BENTHAM SCIENCE PUBL LTD
Language English
Frequency Semi-annual
General Details
LanguageEnglish
FrequencySemi-annual
Publication Start Year2006
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Current Drug Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Current Drug Therapy

Challenges and Innovations in Disintegrating Tablets for Multi-Unit Pellet Systems
  • 30 Apr 2026
  • Current Drug Therapy
Guipi Tang Regulates Metabolic Reprogramming at the Maternal-Fetal Interface in a Mouse Model of Unexplained Recurrent Spontaneous Abortion
  • 29 Apr 2026
  • Current Drug Therapy
Unveiling Synergy: A Tandem RP-HPLC Method for Exemestane and Bosutinib Quantification
  • 29 Apr 2026
  • Current Drug Therapy
Rehmannioside D Inhibits Osteoclast Differentiation and Osteolysis in vitro Through Downregulating the Akt/Runx2 Axis in Mouse Bone Marrow- derived Macrophages
  • 8 Apr 2026
  • Current Drug Therapy
<i>In Silico</i> Evaluation of Quinazoline-Based EGFR Inhibitors with Anticancer Activity
  • 7 Apr 2026
  • Current Drug Therapy
Apixaban Pharmacotherapy Management: A Current and Updated Review
  • 27 Mar 2026
  • Current Drug Therapy
Challenges and Innovations in Disintegrating Tablets for Multi-Unit Pellet Systems
  • 30 Apr 2026
  • Current Drug Therapy
Guipi Tang Regulates Metabolic Reprogramming at the Maternal-Fetal Interface in a Mouse Model of Unexplained Recurrent Spontaneous Abortion
  • 29 Apr 2026
  • Current Drug Therapy
Unveiling Synergy: A Tandem RP-HPLC Method for Exemestane and Bosutinib Quantification
  • 29 Apr 2026
  • Current Drug Therapy
Rehmannioside D Inhibits Osteoclast Differentiation and Osteolysis in vitro Through Downregulating the Akt/Runx2 Axis in Mouse Bone Marrow- derived Macrophages
  • 8 Apr 2026
  • Current Drug Therapy
<i>In Silico</i> Evaluation of Quinazoline-Based EGFR Inhibitors with Anticancer Activity
  • 7 Apr 2026
  • Current Drug Therapy
Apixaban Pharmacotherapy Management: A Current and Updated Review
  • 27 Mar 2026
  • Current Drug Therapy

FAQs on Current Drug Therapy